Bacopa: Memory Evidence, Extracts and How to Read the Label

What is bacopa?

Bacopa (Bacopa monnieri), also called brahmi, is a creeping wetland plant used in Ayurvedic medicine for memory. Supplements sell it as extracts standardized to a set percentage of bacosides, its main active compounds, and as plain powder.

People take bacopa for memory, focus, and stress.

Named extracts include BacoMind, Keenmind (also called CDRI 08), and BaCognize. There is no official daily amount.

Several memory trials tested 300 to 450 mg a day of specific extracts for 12 weeks. Healthy adults remembered word lists somewhat better when tested later, while many other thinking measures did not change.

From Ayurvedic memory use to extract trials

In a translated chapter of the Sushruta Samhita on memory and intellect, the author describes a course of expressed brahmi juice and credits it with helping a person recall a long passage after hearing it. Another preparation combines the juice with clarified butter (ghee) and other plants. ^[1]

Other chapters address different uses. A childcare passage describes a preparation containing ghee, milk, several other ingredients and two kinds of brahmi for a child already eating solid food. It associates the preparation with intellect and strength. In the Charaka Samhita chapter on seizure illness, a formula combines brahmi juice and ghee with several herbs. These were preparations for distinct purposes. The texts give little basis for treating a modern single-herb capsule as a remedy for speech delay, hyperactivity or seizures. Sushruta, Sharira Sthana, chapter 10, verses 36–37^[2] · Charaka, Chikitsa Sthana, chapter 10, verse 25^[3]

India’s National Medicinal Plants Board identifies Bacopa monnieri as brahmi and lists the whole plant as an ingredient of traditional preparations. The common name has also been used for Centella asiatica, or gotu kola. A Latin name on a modern label helps identify the plant. It cannot settle the species of every historical ingredient. ^[4]

Modern memory trials test a narrower question. Participants take a measured amount of extract and later try to recall newly learned words under the same conditions as a placebo group. Some trials found better recall. Others found little difference, even after 12 weeks. For the broader category, see what “adaptogen” means and how it differs from traditional tonic use.

What people take bacopa for

Some trials found better recall of newly learned words after several weeks. Single-dose attention results were mixed. In a recent stress trial, symptoms improved more with one extract than with placebo, while a separate trial found less stress after a demanding task without better scores on its main thinking tests.

Results apply to the preparation and population studied.

When to ask a doctor before taking bacopa

• You have thyroid disease. A bacopa extract increased the thyroid hormone T4 in male mice. Its effect on thyroid levels in people remains uncertain. Discuss use with the clinician managing Graves’ disease or your thyroid medication.
• You have stomach or bowel problems. Stomach upset is the most common side effect.
• You take a dementia medicine, a sedative or a medicine that slows your pulse. The medicine section explains which effects have been measured and which combinations still need an individual review.

All extracts and forms at a glance

These are not interchangeable doses. Each proprietary extract is made and standardized differently, while plain herb powder has no fixed bacoside content.

What to pay attention to on the label

Use three checks. First, find milligrams of standardized extract per serving. Second, note the bacoside or glycoside percentage. Third, check the serving size and whether the same serving also contains plain herb powder.

Which number on the label is the amount?

Look for Bacopa monnieri extract in milligrams with a percentage of bacosides. One BacoMind product lists 300 mg of extract per two capsules, the amount in its trial.

Misleading labels

Front milligrams versus the milligrams that count

One capsule is sold as “Bacopa 500 mg,” but its Supplement Facts panel lists 400 mg of plain herb powder and 100 mg of extract standardized to 20 percent bacosides, which is 20 mg of bacosides. The title combines powder and extract into a larger number, making the capsule look like 500 mg of standardized extract. Its actual extract portion is 100 mg, and the front-label total obscures both the preparation and amount being compared.

Different standardizations

A percentage is useful only if you know what was measured. One label lists 12 percent “bacopa glycosides.” A 2026 stress trial used 300 mg of B-Lit extract standardized to 30 percent total bacosides, or 90 mg of those compounds. Its capsule weighed 500 mg including filler. These numbers describe three different things. Percentages from different assays cannot establish an equivalent dose or predict how a different extract will perform.

^[5]

Blends

One brain blend lists 300 mg of BacoMind alongside a 150 mg proprietary blend of turmeric, blueberry, lion’s mane, and eleuthero. The BacoMind memory trial tested that extract for 12 weeks. Its findings can inform a comparison with the declared BacoMind portion, but the trial did not test this complete blend. The amount of each additional ingredient remains undisclosed.

Confusing servings and items per serving

Some manufacturers put 180 capsules on the front, and the back says 3 capsules per serving and 60 servings. The amount on the Supplement Facts panel is for the whole 3-capsule serving.

Common Myths about Bacopa

Does bacopa raise blood pressure?

In the older-adult trial, bacopa did not clearly change blood pressure compared with placebo. The researchers also measured pulse; those findings are discussed with the medicine interactions below.

Drawbacks and side effects

Stomach cramps, nausea and more frequent bowel movements were more common with BacoMind than with placebo in the older-adult trial. A later trial of a different extract also recorded more adverse reactions, mainly digestive complaints and headaches. Neither comparison varied the size or fat content of the meal. Taking a dose with food was part of some study protocols. A requirement for a heavy or high-fat meal, whether for absorption or stomach comfort, remains untested in those comparisons. BacoMind trial^[7] · Bacumen trial and registration^[8]

Thyroid, pulse and medicines

The thyroid experiment used a leaf extract at 200 mg per kilogram in male mice. ^[9]

In one older-adult trial, average pulse changed from about 69 to 68 beats per minute on bacopa, compared with 67 to 72 on placebo. A change in a group’s average pulse gives no rate of clinically dangerous slow heartbeat. If you already have a slow pulse or take a beta-blocker, discuss the combination before use. ^[10]

For someone taking donepezil or a medicine that blocks acetylcholine, the concern is whether adding bacopa changes the medicine’s effect on this brain chemical. With a sedative, the practical question is whether the combination adds to drowsiness. Clinical studies here do not quantify these effects in patients. A pharmacist can review the specific medicine, dose and extract together.

There is no official upper limit. The usual adult memory trials provide much more information about several weeks of use than about years of daily use.

Pregnancy

Bacopa has not been studied in pregnancy or breastfeeding, so do not take it during either.

The science behind bacopa

After several weeks of use, some trials found modest gains on specific memory tests. Digestive side effects were common, and the dementia evidence remains inconclusive.

Some extracts improved delayed recall

In the Calabrese trial^[11], 48 older adults completed 12 weeks. With 300 mg daily of a MediHerb extract, the average number of words recalled after a delay rose from 6.4 to 7.6. Placebo averages were 6.8 and 6.9. The paper tested the change over time within each group, which leaves the size of the treatment advantage uncertain. MediHerb supplied the tablets, and a company director was a co-author. In the BacoMind trial^[7], 81 adults over 55 completed the study. Delayed word recall favored BacoMind, while differences on a figure-recall test and a questionnaire about everyday memory complaints were statistically unclear. A separate 2008 KeenMind trial^[12] used two 150 mg doses daily for 90 days and reported improvements on a working-memory measure and fewer false responses. Only 62 of 107 recruited participants completed it.

A 2012 review of six 12-week trials using 300–450 mg a day of standardized extracts found better free-recall memory—recalling a list without hints—on 9 of 17 tests, with little evidence of change in other kinds of thinking. In a 2002 trial of 76 adults aged 40 to 65, bacopa helped people retain new information but did not speed up learning.

Four weeks. In a 60-person trial of healthy older adults, a university-prepared extract at 300 mg daily improved two measures of attention and memory quality compared with placebo by week four. Some other measures separated later, and results differed between 300 and 600 mg. ^[13]

Six weeks. A trial in medical students tested BaCognize at 150 mg twice daily. Two results favored bacopa: repeating digits backwards and recalling a story. The groups started at different scores. Most of the other tests, including reaction time, did not show a clear difference. ^[14]

A trial that measures recall only at its final visit can establish a difference at that visit. It cannot tell us when the difference first appeared.

The 2002 Roodenrys trial received its extract and placebo from Keenmind Pty Ltd. Separate cash funding and author interests could not be established from the available publisher information.

A later trial puts the positive recall findings in perspective. Researchers assigned 101 adults aged 40 to 70 who noticed problems with their memory or attention to Bacumen 300 mg daily or placebo. At 12 weeks, the 87 completers showed no clear difference on any of the three primary outcomes: verbal learning, attention or working memory. Forty of 50 assigned bacopa completed the study, compared with 47 of 51 assigned placebo. The supplier funded the trial and provided both capsules. ^[15]

A 2026 review combined results across studies of bacopa, ginkgo and placebo. For working memory, its estimated difference between bacopa at 600 mg or more per day and placebo was about two standard deviations, an unusually large difference on a scale used to compare results from different tests. The review also compared high-dose bacopa with lower-dose bacopa and with ginkgo. The unusually large estimate remains difficult to reconcile with the modest changes in individual trials. ^[16]

Same-day attention, stress and cortisol

Small single-dose studies give mixed results. In Nathan’s study^[17], a 300 mg dose did not significantly change the tests performed two hours later in 38 adults. A KeenMind crossover study with 24 completers^[18] reported better performance in some repetitions of a demanding task after 320 mg, but no improvement in task-related stress or fatigue.

A different crossover report with 17 completers^[19] tested 320 mg and 640 mg. It reported selected attention-task and mood improvements and lower salivary cortisol during a multitasking experiment. Its abstract does not separate the two doses’ results. These small experiments do not establish an effective treatment for an anxiety disorder.

Some stress scores improved over several weeks

In the Bacumen trial, participants reported less stress reactivity and less fatigue or stress after a demanding task, even though the primary thinking tests showed little difference. Researchers also compared three blood measurements. These measured an enzyme that breaks down acetylcholine, a marker of oxidative damage, and a protein involved in nerve growth. None showed a clear difference between groups. ^[15]

A smaller manufacturer-funded trial tested 300 mg of B-Lit extract in a capsule after breakfast in 50 adults with recent stress. Among 44 completers, perceived stress improved more than with placebo by day 14. The change in anxiety scores was not clearly different then, but favored the extract by day 28. Serum cortisol was measured at baseline and day 84 and fell more with the extract. These results concern stress symptoms in the enrolled adults. People with diagnosed psychiatric illness were excluded. ^[5]

Alzheimer’s disease

A 2022 review covered five small reports across Alzheimer’s disease, age-associated memory impairment and self-reported memory complaints; three used combination products rather than bacopa alone. Design weaknesses could skew the results. The review found no clear difference in its comparisons with placebo or donepezil, an Alzheimer’s drug, but the evidence was too weak to say bacopa works as well as the drug or treats Alzheimer’s disease.

A mouse study helps explain interest in amyloid, a protein that accumulates in Alzheimer’s disease. In genetically modified mice given bacopa extract, the researchers found lower levels of two amyloid-beta peptides in the brain’s cortex. The area occupied by stained amyloid deposits did not change. Peptide concentration and plaque area gave different answers in the same animals. Human prevention would require evidence that people taking bacopa were less likely to develop dementia. ^[20]

What did the study in children find?

A 14-week placebo-controlled trial recruited 112 boys aged 6 to 14 with inattention and hyperactivity. Researchers analyzed 93 datasets. Behavior did not clearly improve more with CDRI 08 than with placebo. There were differences on some secondary measures, including fewer errors with bacopa, while reaction speed improved with placebo. The study provides a modern test of behavioral claims in school-age children. ^[21]

What is still open

The practical question is whether gains on selected tests change what people remember at home, school or work. The studies leave that uncertain, along with the long-term safety of taking a retail extract every day.

The bottom line

Some standardized extracts improved delayed word recall after weeks of daily use. A separate 12-week trial found little difference in learning or attention. A four-week attention result and a two-week stress result concern separate tasks and preparations. There is no established week-by-week sequence from calm focus to memory improvement.

Stomach symptoms are the most consistent drawback, and the evidence for Alzheimer’s treatment remains insufficient.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly